Evidence map›Paper›PMID 35119226›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022

Phenotype-Based Isolation of Antigen-Specific CD4

Asbjørn Christophersen, Shiva Dahal-Koirala, Markéta Chlubnová, Jørgen Jahnsen, Knut E A Lundin, Ludvig M Sollid

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Gliadin-specific CD4Science advances · 2026
    Article
  2. Detection of Gliadin-Activated CD4Journal of cellular and molecular medicine · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Phenotype-Based Isolation of Antigen-Specific CD4Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Asbjørn ChristophersenKG Jebsen Coeliac Disease Research Centre, University of Oslo, Oslo, 0372, Norway.ORCID 0000-0003-4049-807X
Shiva Dahal-KoiralaKG Jebsen Coeliac Disease Research Centre, University of Oslo, Oslo, 0372, Norway.ORCID 0000-0002-0165-5098
Markéta ChlubnováKG Jebsen Coeliac Disease Research Centre, University of Oslo, Oslo, 0372, Norway.
Jørgen JahnsenDepartment of Gastroenterology, Akershus University Hospital, Lørenskog, 1478, Norway.ORCID 0000-0002-0419-2914
Knut E A LundinKG Jebsen Coeliac Disease Research Centre, University of Oslo, Oslo, 0372, Norway.ORCID 0000-0003-1713-5545
Ludvig M SollidKG Jebsen Coeliac Disease Research Centre, University of Oslo, Oslo, 0372, Norway.ORCID 0000-0001-8860-704X
Oslo University Hospital · NOUniversity of Oslo · NOAkershus University Hospital · NO

Funding

Oslo University Hospital best paper awards 2017 and 2019South-Eastern Norway Regional Health Authority 2016113South-Eastern Norway Regional Health Authority 2018068Stiftelsen KG Jebsen SKGJ-MED-017University of Oslo World-leading research program on human immunology WL-IMMUNOLOGY
6 · The paper itself

Abstract

The pathogenic immune response in celiac disease (CeD) is orchestrated by phenotypically distinct CD4

Indexed as

Celiac DiseaseAutoimmunityCD4-Positive T-LymphocytesHumansPhenotypeT-Lymphocytesantigen-specific T cellsautoimmunityceliac diseaseHLA tetramersT cells

Identifiers

PMID35119226
PMCPMC8981484
OpenAlexW4210475280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.